Cultured epidermal autografts have been used worldwide since 1981 for patients with extensive third-degree burn wounds and limited skin donor sites. Despite significant progress in techniques toward improving clinical outcome of skin grafts, the long in vitro preparation time of cultured autografts has remained a major factor limiting its widespread use. Here, we show that pharmacological inhibition of TGF-b signaling promotes the expansion of human epidermal keratinocytes (HEKs) with high proliferative potential in co-cultures with both murine 3T3-J2 cells and human feeder cells, including dermal fibroblasts and preadipocytes. In contrast, TGF-b signaling inhibition does not enhance the growth of HEKs in a serum-and feeder-free condition, an alternative approach to propagate HEKs for subsequent autograft production. Our results have important implications for the use of TGF-b signaling inhibition as a viable therapeutic strategy for improving Green's methodology and for more efficient production of customized skin autografts with human feeder cells.
Cutaneous burns are one of the most common and devastating forms of trauma. Patients with extensive third-degree burn wounds require immediate treatment to minimize morbidity and mortality, for which many synthetic and allogeneic skin substitutes have been developed and successfully used as a temporary coverage of the wounds. [1] [2] [3] However, to achieve permanent wound closure, autologous keratinocytes with high proliferative potential must be used. Since 1981, cultured epidermal autografts (CEA) developed by Green and colleagues have been used worldwide for patients with massive burn wounds and limited skin donor sites, saving their lives. 4 Green's method to expand human epidermal keratinocytes (HEKs) utilizes 3T3-J2 cells, a murine mesenchymal cell line, as a feeder layer. 4 A modified Green's method has implemented the use of a fibrin matrix underneath the 3T3-J2 cell layer to improve the handling of the grafts at the surgery, which has successfully increased the number of grafts to be transplanted at a time. 1, [4] [5] [6] [7] However, the long in vitro expansion time to prepare autografts from a small skin biopsy has remained one of the major factors limiting widespread use of CEA. It has been shown that a feeder-free culture can reduce the time required for HEK expansion. 8, 9 However, although keratinocyte autografts prepared in a feeder-free culture have been used in treating relatively small wounds, such as chronic venous leg ulcers, 10 few burn units implement feeder-free autografts for patients with severe burn wounds. 2 An improved methodology to more rapidly expand keratinocytes with high proliferative potential in 3T3-J2 co-culture would reduce the number of surgical procedures and decrease hospitalization time for patients with massive burn injuries who undergo replacement by Green's method of skin covering nearly the entire body surface area.
We have shown recently that 3T3-J2 cells express Dact1, an antagonist of b-catenin signaling that suppresses keratinocyte-mediated upregulation of TGF-b in 3T3-J2 cells.
11 As TGF-b suppresses keratinocyte proliferation, 12 the relative inability of 3T3-J2 cells to upregulate this inhibitory cytokine may contribute to their support of long-term proliferation of HEKs. However, although predominantly latent, TGF-b is also found in serum, a key component of 3T3-J2 co-culture, and is activated by a number of cellular mechanisms, 13 which in turn restricts potential growth of HEKs in 3T3-J2 co-culture.
The specific aim of this study was, first, to investigate whether pharmacological inhibition of TGF-b signaling promotes the expansion of HEKs with high proliferative potential in 3T3-J2 co-culture. Second, we aimed at investigating if TGF-b signaling inhibition would also promote the expansion of HEKs in co-culture with human dermal fibroblasts and preadipocytes, two major human cell types utilized as alternatives to 3T3-J2 cells, 14, 15 with a long-term goal of efficiently generating customized skin autografts.
METHODS

Cell culture
HEKs (gift from J. Seykora, University of Pennsylvania School of Medicine) were grown in CnT-PR media (Cellntec) or chemically-defined SFM media supplemented with growth factors (Invitrogen) in a humidified chamber at 378C with 5% CO 2 . To induce differentiation of keratinocytes, the cells were harvested from 3T3-J2 co-cultures and keratinocytes were selectively expanded in CnT-PR media, followed by stimulation with 1.3 mM CaCl 2 for 6 days. 3T3-J2 cells (gift from H. Green, Harvard Medical School) and human dermal fibroblasts (hDF) (Genlatis) were grown in DMEM containing 10% calf serum (Hyclone), 10 U/ml penicillin and 100 lg/ml streptomycin in a humidified chamber at 378C with 10% CO 2 . Human preadipocytes (hPA) (gift from M. Reilly, University of Pennsylvania School of Medicine) were grown in PM4 medium as described. 16 3T3-J2 co-culture was performed according to the Green method. 17 To visualize epidermal cell clones, the culture plates were stained with 1% Rhodamine B (Sigma-Aldrich). RepSox, LY364947, and SB525334 were purchased from Selleck Chemicals.
Antibodies
The following antibodies were used in this study: mouse anti-p63 (Santa Cruz), rabbit anti-cytokeratin 5 (Abcam), rabbit anti-integrin b1 (Abcam), rabbit anti-loricrin (Covance), goat anti-involucrin (Santa Cruz), mouse anti-tubulin a (Developmental Studies Hybridoma Bank), mouse antiBrdU (Roche), rabbit anti-Smad2/3 (Cell Signaling), Alexa 488-goat anti-mouse IgG, Alexa 488-goat anti-rabbit IgG, Alexa 594-goat anti-rabbit IgG, R-phycoerythrin-goat antimouse IgG (Molecular Probes), horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (KPL), HRPconjugated rabbit anti-goat IgG (Invitrogen), and HRPconjugated goat anti-rabbit IgG (Cell Signaling).
Protein analysis
Immunofluorescence and Western blot were performed as previously described.
11
BrdU labeling
BrdU labeling and detection were performed as previously described.
11 CK5
1 BrdU 1 cell populations were analyzed on a FACSCanto II (BD Biosciences).
Statistical analysis
Values are reported as mean 6 standard error of the mean (SEM). Student's t-tests were performed where p < 0.05 was considered statistically significant.
RESULTS
To determine whether TGF-b signaling is active in proliferating HEKs in 3T3-J2 co-culture, we investigated the nuclear localization of Smad2/3, downstream effectors of activated TGF-b signaling. 18 Our data show that a substantial fraction of Smad2/3 was found in the nucleus of HEKs and that treatment with RepSox, a small molecule inhibitor of the TGF-b type 1 receptor (TGFbRI/ALK5), 19 significantly reduced the nuclear localization of Smad2/3 ( Figure  1A and B). These data indicate that TGF-b signaling is active in proliferating HEKs in 3T3-J2 co-culture.
Our data show that proliferation of HEKs was significantly enhanced by the treatment with RepSox, as determined by a short pulse labeling with 5-bromo-2'-deoxyuridine (BrdU) ( Figure 1C ). Accordingly, RepSox treatment enhanced the clonal expansion of HEKs, yielding a >2.4-fold increase in the percentage of the largest epidermal clones (>5 mm in diameter) compared to untreated controls (76.2 6 8.1% vs. 31.2 6 3.3%, p < 0.05) at day 14 ( Figure 1D-F) . Treatment with LY364947 and SB525334, two other TGFbRI/ALK5 inhibitors, 20,21 also enhanced the growth of HEKs in 3T3-J2 co-culture (Supporting Information Figure S1 ). Specificity of the TGF-b signaling inhibitors used in this study is summarized in Supporting Information Table S1 . Flowcytometric analysis with an anti-cytokeratin 5 (CK5) antibody, a marker of basal epidermal cells, shows that RepSox-treated cultures produced 5.3-fold more CK5
1 keratinocytes than did untreated control cultures at day 8 ( Figure 1G ). At day 14, when RepSox-treated cultures approached confluence, they produced 6.5-fold more CK5
1 keratinocytes than did untreated control cultures ( Figure 1H) . Notably, we found that RepSox treatment did not enhance the growth of HEKs in a serum-and feeder-free condition (Supporting Information Figure S2 ). These data indicate that inhibition Because the use of keratinocytes with high proliferative capacity is essential for wound healing success, we determined the clone-forming efficiency of RepSox-treated HEKs in serial 3T3-J2 co-cultures. 17 Immunofluorescence staining shows that, at the end of the initial two-week culture, keratinocytes within the largest epidermal clones in both RepSox-treated and -untreated cultures expressed similar levels of p63, a marker for epidermal progenitor cells 22 ( Figure 1I ). We plated equal numbers of epidermal cells harvested from both cultures and assessed the distribution of clone sizes in multiple passages with two-week intervals in the absence of RepSox ( Figure 1J ). Our data show that epidermal cells expanded by RepSox treatment produced large clones (>5 mm in diameter) at similar frequencies to those of untreated HEKs derived from standard 3T3-J2 co-cultures in multiple passages ( Figure 1K ). These data indicate that RepSox treatment does not impair high proliferative capacity of epidermal progenitor cells.
To determine the ability of RepSox-treated keratinocytes to differentiate, we harvested epidermal cells from RepSox-treated and -untreated 3T3-J2 co-cultures and allowed them to differentiate in response to Ca 21 stimulation in CnT-PR keratinocyte basal media. Western blot analysis shows that on stimulation with Ca 21 , expressions of both p63 and a basal cell marker integrin b1 decreased in keratinocytes harvested from RepSox-treated cultures to similar extents to those in control cultures (Supporting Information Figure S3 ). In addition, expressions of both loricrin and involucrin, markers for terminal differentiation of epidermal cells, increased in keratinocytes harvested from RepSox-treated cultures to similar levels to those in control cultures (Supporting Information Figure S3 ). These data indicate that HEKs treated with RepSox are capable of differentiation in response to Ca 21 stimulation. Finally, we investigated if TGF-b signaling inhibition promotes the expansion of HEKs with high proliferative potential in co-cultures with human feeder cells. Our data show that RepSox treatment drastically enhanced the expansion of HEKs in co-culture with both dermal fibroblasts 14 and preadipocytes 15 in a dose-dependent manner (Figure 2A-C) . In addition, RepSox-treated HEKs harvested from human feeder cell co-cultures maintained high proliferative capacity in subsequent 3T3-J2 co-cultures in the absence of RepSox to the extent similar to that of untreated HEKs in standard 3T3-J2 co-cultures ( Figure 2D and E). These data indicate that inhibition of TGF-b signaling promotes the expansion of keratinocytes with high proliferative potential in co-culture with human feeder cells.
DISCUSSION
We have shown that pharmacological inhibition of TGF-b signaling promotes the expansion of HEKs with high proliferative potential in co-cultures with both murine 3T3-J2 cells ( Figure 1 ) and human feeder cells (Figure 2 ). In contrast, RepSox treatment did not enhance the growth of HEKs in a serum-and feeder-free condition (Supporting Information Figure S2 ). Serum-free monoculture can expand HEKs 8, 9 and has recently been implemented in therapies for small wounds. 10 Co-culture of HEKs on feeder cells, however, is still widely used for therapies involving major burn wounds that require much larger autografts.
1,2,4 Thus, our results have important implications for more rapid generation of CEA in Green's methodology and for the use of TGF-b signaling inhibition as a viable therapeutic strategy for efficient production of customized skin autografts with human feeder cells.
There are limitations to our study. First, while we have shown that RepSox-treated HEKs are capable of both proliferation in serial 3T3-J2 co-cultures and differentiation in response to Ca 21 stimulation, further analysis would be necessary to assure long-term capabilities of self-renewal and differentiation, while avoiding immortality, in transplantation models in vivo. Second, we utilized fetal bovine serum (FBS) in feeder cell co-cultures based on the Green protocol. 17 Although the use of FBS for therapeutic expansion of HEKs in 3T3-J2 co-culture has been approved by the US Food and Drug Administration, 4 human serum can potentially replace FBS and contribute to the development of xenobiotic-free epithelial cell cultures. 15 Third, it is important to determine if the presence of supportive matrices (e.g., a fibrin matrix) interferes with biological activities of TGF-b signaling inhibitors during preparation of CEA. Finally, we have not investigated in this study if alterations of feeder cells mediated by TGF-b signaling inhibition would impact keratinocyte proliferation.
We have shown recently that RepSox treatment could rescue HEK-mediated decrease of Igf2, a growthpromoting factor of keratinocytes, in 3T3-J2 cells. 11 This can potentially contribute to the TGF-b signaling inhibition-mediated increase of HEK growth in 3T3-J2 coculture. However, other effects mediated by TGF-b signaling inhibition in feeder cells need to be fully investigated to explore if such information can be utilized to further improve rapid production of CEA in future studies. While our results are provocative, additional anti-TGF-b compounds currently in clinical trials for different diseases 23 should also be investigated to see if they help to promote therapeutic expansion of keratinocytes suitable for clinical use. 
Supporting Information
Additional Supporting Information may be found in the online version of this article at the publisher's website: Figure S1 . Growth response of HEKs to LY364947 and SB525334 in 3T3-J2 co-culture. Three thousand HEKs per well were grown in 12-well plates in 3T3-J2 co-culture in the absence or presence of TGF-b signaling inhibitors LY364947 and SB525334. (A) Rhodamine B staining of epidermal cell clones grown in the absence (DMSO) or presence of 1.0 mM TGF-b signaling inhibitors as indicated for 14 days. Bar55 mm. (B) Epidermal cell numbers at day 14, expressed as mean6SEM (n53). *p<0.05; **p<0.01; ***p<0.001. Figure S2 . Growth response of HEKs to TGF-b signaling inhibition in serum-and feeder-free culture. Two thousand HEKs per well were grown in 12-well plates in serum-free SFM media without feeder cells in the absence or presence of increasing concentrations of RepSox as indicated for 12 days. Data shown are mean6SEM (n53). *p<0.05; ***p<0.001; ns, not significant. Figure S3 . Differentiation of RepSox-expanded HEKs in response to calcium (Ca 21 ) stimulation. Keratinocytes were harvested from 3T3-J2 co-cultures treated with DMSO or 0.1 mM RepSox and expanded in CnT-PR keratinocyte basal media to deplete contaminating feeder cells, followed by stimulation with 1.3 mM Ca 21 for 6 days. Equal amounts of proteins were applied in each lane and Western blot analysis was performed using antibodies as indicated. Tubulin a was used as a loading control. Table S1 . Specificity of the TGF-b signaling inhibitors used in this study.
